- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jeffrey Brenner Talks Hospital Super Utilizers in Camden, NJ
The first job of the Camden Coalition of Healthcare Providers was to dig into the data of the city's hospitals and see who was using them. Half of the population, it turns out, according to Jeffrey Brenner, MD, chief executive officer of the Coalition.
The first job of the Camden Coalition of Healthcare Providers was to dig into the data of the city’s hospitals and see who was using them. Half of the population, it turns out, according to Jeffrey Brenner, MD, chief executive officer of the Coalition.
He discovered that just 1% of the population accounted for 30% of hospital spending in the city, and his own patients were in the database he had. His own primary care practice was struggling to stay open, but hospitals were building new wings.
“It speaks volumes about how broken the system is,” Dr Brenner said. “It shows that we’re spending money in all the wrong places.”
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
